HLS Therapeutics (OTCMKTS:HLTRF) Stock Price Up 5.3% – Here’s What Happened

HLS Therapeutics Inc. (OTCMKTS:HLTRF) shot up 5.3% during trading on Friday . The company traded as high as $3.38 and last traded at $3.38. 1,000 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 2,275 shares. The stock had previously closed at $3.21.

HLS Therapeutics Price Performance

The stock’s 50 day simple moving average is $3.25 and its 200 day simple moving average is $3.48.

HLS Therapeutics Company Profile

HLS Therapeutics is a specialty pharmaceutical company focused on the development, acquisition and commercialization of prescription products for niche therapeutic markets. Headquartered in Mississauga, Ontario, the company builds its portfolio through strategic licensing agreements and in-house development, with an emphasis on therapies that address unmet needs in neurology and rare disorders.

The company’s marketed offering includes treatments for neurological conditions, most notably primary periodic paralysis, for which it commercializes dichlorphenamide (Keveyis) in North America.